TREATMENT FOR STAGE I NONSEMINOMATOUS TESTICULAR GERM CELL TUMORS
Overall survival is about 100 % in patients with stage I testicular germ cell tumors after orchofuniculectomy, which is achieved, by applying alternative adjuvant approaches. Methods, such as a follow-up, chemotherapy or retroperitoneal lymphadenectomy, may be used to treat nonseminomatous germ cell...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2014-07-01
|
Series: | Onkourologiâ |
Subjects: | |
Online Access: | https://oncourology.abvpress.ru/oncur/article/view/44 |
id |
doaj-bed9b370fbef4cffb31ba35748220ed7 |
---|---|
record_format |
Article |
spelling |
doaj-bed9b370fbef4cffb31ba35748220ed72021-07-29T08:41:36ZrusABV-pressOnkourologiâ 1726-97761996-18122014-07-0171101510.17650/1726-9776-2011-7-1-10-1559TREATMENT FOR STAGE I NONSEMINOMATOUS TESTICULAR GERM CELL TUMORSE. A. Burova0A. A. Bulanov1A. A. Tryakin2M. Yu. Fedyanin3V. B. Matveev4S. A. Tulandin5Russian Cancer Research Center, Russian Academy of Medical Sciences, MoscowRussian Cancer Research Center, Russian Academy of Medical Sciences, MoscowRussian Cancer Research Center, Russian Academy of Medical Sciences, MoscowRussian Cancer Research Center, Russian Academy of Medical Sciences, MoscowRussian Cancer Research Center, Russian Academy of Medical Sciences, MoscowRussian Cancer Research Center, Russian Academy of Medical Sciences, MoscowOverall survival is about 100 % in patients with stage I testicular germ cell tumors after orchofuniculectomy, which is achieved, by applying alternative adjuvant approaches. Methods, such as a follow-up, chemotherapy or retroperitoneal lymphadenectomy, may be used to treat nonseminomatous germ cell tumors. The paper shows the main advantages and disadvantages of the above treatment options.https://oncourology.abvpress.ru/oncur/article/view/44nonseminomatous testicular germ cell tumorstreatmentfollow-upchemotherapyretroperitoneal lymphadenectomy |
collection |
DOAJ |
language |
Russian |
format |
Article |
sources |
DOAJ |
author |
E. A. Burova A. A. Bulanov A. A. Tryakin M. Yu. Fedyanin V. B. Matveev S. A. Tulandin |
spellingShingle |
E. A. Burova A. A. Bulanov A. A. Tryakin M. Yu. Fedyanin V. B. Matveev S. A. Tulandin TREATMENT FOR STAGE I NONSEMINOMATOUS TESTICULAR GERM CELL TUMORS Onkourologiâ nonseminomatous testicular germ cell tumors treatment follow-up chemotherapy retroperitoneal lymphadenectomy |
author_facet |
E. A. Burova A. A. Bulanov A. A. Tryakin M. Yu. Fedyanin V. B. Matveev S. A. Tulandin |
author_sort |
E. A. Burova |
title |
TREATMENT FOR STAGE I NONSEMINOMATOUS TESTICULAR GERM CELL TUMORS |
title_short |
TREATMENT FOR STAGE I NONSEMINOMATOUS TESTICULAR GERM CELL TUMORS |
title_full |
TREATMENT FOR STAGE I NONSEMINOMATOUS TESTICULAR GERM CELL TUMORS |
title_fullStr |
TREATMENT FOR STAGE I NONSEMINOMATOUS TESTICULAR GERM CELL TUMORS |
title_full_unstemmed |
TREATMENT FOR STAGE I NONSEMINOMATOUS TESTICULAR GERM CELL TUMORS |
title_sort |
treatment for stage i nonseminomatous testicular germ cell tumors |
publisher |
ABV-press |
series |
Onkourologiâ |
issn |
1726-9776 1996-1812 |
publishDate |
2014-07-01 |
description |
Overall survival is about 100 % in patients with stage I testicular germ cell tumors after orchofuniculectomy, which is achieved, by applying alternative adjuvant approaches. Methods, such as a follow-up, chemotherapy or retroperitoneal lymphadenectomy, may be used to treat nonseminomatous germ cell tumors. The paper shows the main advantages and disadvantages of the above treatment options. |
topic |
nonseminomatous testicular germ cell tumors treatment follow-up chemotherapy retroperitoneal lymphadenectomy |
url |
https://oncourology.abvpress.ru/oncur/article/view/44 |
work_keys_str_mv |
AT eaburova treatmentforstageinonseminomatoustesticulargermcelltumors AT aabulanov treatmentforstageinonseminomatoustesticulargermcelltumors AT aatryakin treatmentforstageinonseminomatoustesticulargermcelltumors AT myufedyanin treatmentforstageinonseminomatoustesticulargermcelltumors AT vbmatveev treatmentforstageinonseminomatoustesticulargermcelltumors AT satulandin treatmentforstageinonseminomatoustesticulargermcelltumors |
_version_ |
1721252723303645184 |